About SkinCure Oncology
SkinCure Oncology is a company based in Chicago (United States) founded in 2016 by Kerwin Brandt.. SkinCure Oncology has raised $33.47 million across 7 funding rounds from investors including Seacoast Capital and Capx Partners. SkinCure Oncology offers products and services including Image-Guided SRT. SkinCure Oncology operates in a competitive market with competitors including US Oncology Network, OneOncology, The Oncology Institute of Hope and Innovation, 21st Century Oncology and Memorial Sloan - Kettering Cancer Center, among others.
- Headquarter Chicago, United States
- Founders Kerwin Brandt
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Skin Cure Oncology, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33.47 M (USD)
in 7 rounds
-
Latest Funding Round
$30 M (USD), Series C
Aug 01, 2019
-
Investors
Seacoast Capital
& 1 more
-
Employee Count
Employee Count
-
Acquired by
(Oct 01, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SkinCure Oncology
SkinCure Oncology offers a comprehensive portfolio of products and services, including Image-Guided SRT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive option for treating non-melanoma skin cancer with high cure rates.
Unlock access to complete
Funding Insights of SkinCure Oncology
SkinCure Oncology has successfully raised a total of $33.47M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $30.0M
-
First Round
First Round
(19 Sep 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Series C - SkinCure Oncology | Valuation | Seacoast Capital |
|
| Apr, 2019 | Amount | Seed - SkinCure Oncology | Valuation |
investors |
|
| Mar, 2018 | Amount | Debt – Conventional - SkinCure Oncology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SkinCure Oncology
SkinCure Oncology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Seacoast Capital and Capx Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-control growth capital is provided to management teams.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward growth-stage companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SkinCure Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SkinCure Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Skincure Oncology Comparisons
Competitors of SkinCure Oncology
SkinCure Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as US Oncology Network, OneOncology, The Oncology Institute of Hope and Innovation, 21st Century Oncology and Memorial Sloan - Kettering Cancer Center, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cancer care is provided through a nationwide network of hospitals.
|
|
| domain | founded_year | HQ Location |
Independent community oncology practices are partnered for care support.
|
|
| domain | founded_year | HQ Location |
Cancer care services are delivered via a hospital chain.
|
|
| domain | founded_year | HQ Location |
Cancer care is provided through a network of specialized hospitals.
|
|
| domain | founded_year | HQ Location |
Oncology hospitals focused on cancer care and research are maintained.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered via a network of specialized hospitals.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Skincure Oncology
Frequently Asked Questions about SkinCure Oncology
When was SkinCure Oncology founded?
SkinCure Oncology was founded in 2016.
Where is SkinCure Oncology located?
SkinCure Oncology is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of SkinCure Oncology?
Kerwin Brandt is the current CEO of SkinCure Oncology. They have also founded this company.
Is SkinCure Oncology a funded company?
SkinCure Oncology is a funded company, having raised a total of $33.47M across 7 funding rounds to date.
What does SkinCure Oncology do?
SkinCure Oncology was established in 2016 in Chicago, United States, as a network of cancer care hospitals. Operations focus on the oncology sector, with treatments including radiotherapy, stereotactic radiation therapy (SRT), and Mohs surgery delivered across facilities. Services are tailored to skin cancer management, supporting clinical care in the United States.
Who are the top competitors of SkinCure Oncology?
SkinCure Oncology's top competitors include Memorial Sloan - Kettering Cancer Center, Banner MD Anderson Cancer Center and OneOncology.
What products or services does SkinCure Oncology offer?
SkinCure Oncology offers Image-Guided SRT.
Who are SkinCure Oncology's investors?
SkinCure Oncology has 2 investors. Key investors include Seacoast Capital, and Capx Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.